Houston Methodist Hospital researchers have advanced a potential treatment for metaplastic breast cancer—the most aggressive subtype of triple negative breast cancer, into patients in just under four ...

ANN ARBOR, Mich., Jan. 6 (UPI) --Researchers from the University of Michigan Comprehensive Cancer Center have found a key genetic driver for a rare form of breast cancer. Dr. Celina Kleer, Harold A.

CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates, ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression. Houston Methodist and a ...

Houston Methodist Hospital researchers have advanced a potential treatment for metaplastic breast cancer--the most aggressive subtype of triple negative breast cancer, into patients in just under four ...

As our understanding of breast cancer grows, it’s clear treatment will not be the same for each person. Our mission is to research each rare cancer type so we can improve treatments. Out of every 100 ...

Epoetin-alpha reduces red blood cell transfusions (RBC) in high-risk breast cancer patients with adjuvant dose-dense, sequential chemotherapy with epirubicin (E), paclitaxel (T) and cyclophosphamide ...

Phyllodes tumors (PTs) are rare, fibroepithelial tumors of the breast that can arise as benign, borderline or malignant. Little is known about the molecular mechanisms behind their occurrence, and it ...

A Poway mother has turned her grief into raising funds for cancer research. Dale Kaufman has raised over $30,000 over the past three years in memory of her daughter, Jackie Kaufman Tauber, who died of ...